Paper17510412
Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.
Ho MM and 3 others. Cancer Res, 2007. Cited by 765 papers, by iCite.
Cite this record
ConductScience Library. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Papers, record 17510412. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17510412
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung Neoplasms | Major topic |
| Neoplastic Stem Cells | Major topic |
| ATP-Binding Cassette Transporters | |
| Antigens, CD34 | |
| CD24 Antigen | |
| Cell Cycle Proteins | |
| DNA-Binding Proteins | |
| Drug Resistance, Multiple | |
| Drug Resistance, Neoplasm | |
| Flow Cytometry | |
| Humans | |
| Hyaluronan Receptors | |
| Minichromosome Maintenance Complex Component 7 | |
| Neoplasm Invasiveness | |
| Nuclear Proteins | |
| RNA, Messenger | |
| Telomerase | |
| Up-Regulation |
Source PubMed
Cited by459
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 765 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42043154 | ABCG2 Genetic Variability in Drug Exposure and Toxicity: Implications for Clinical Practice. | Toxics | 2026 | https://conductscience.org/library/papers/42043154 | PubMed |
| 40820463 | Formulation and in vitro Evaluation of Targeted Chemotherapy of Crizotinib-loaded polymeric Nanoparticles on Cancer Cell Lines. | Curr Pharm Des | 2026 | https://conductscience.org/library/papers/40820463 | PubMed |
| 40211726 | Natural bioactive gallic acid shows potential anticancer effects by inhibiting the proliferation and invasiveness behavior in human embryonic carcinoma cells. | Mol Med Rep | 2025 | https://conductscience.org/library/papers/40211726 | PubMed |
| 39930823 | Circular RNAs in cancer stem cells: Insights into their roles and mechanisms (Review). | Int J Mol Med | 2025 | https://conductscience.org/library/papers/39930823 | PubMed |
| 39766358 | PLGA-Nano-Encapsulated Disulfiram Inhibits Cancer Stem Cells and Targets Non-Small Cell Lung Cancer In Vitro and In Vivo. | Biomolecules | 2024 | https://conductscience.org/library/papers/39766358 | PubMed |
| 39614090 | The changing treatment landscape of EGFR-mutant non-small-cell lung cancer. | Nat Rev Clin Oncol | 2025 | https://conductscience.org/library/papers/39614090 | PubMed |
| 39408719 | Stilbene Treatment Reduces Stemness Features in Human Lung Adenocarcinoma Model. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39408719 | PubMed |
| 39218931 | Circulating tumor cells: from new biological insights to clinical practice. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39218931 | PubMed |
| 38775844 | Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol. | Cell Mol Life Sci | 2024 | https://conductscience.org/library/papers/38775844 | PubMed |
| 38765006 | Extracellular vesicles in non-small cell lung cancer stemness and clinical applications. | Front Immunol | 2024 | https://conductscience.org/library/papers/38765006 | PubMed |
| 38530545 | Glioblastoma stem cell metabolism and immunity. | Cancer Metastasis Rev | 2024 | https://conductscience.org/library/papers/38530545 | PubMed |
| 38288804 | Targeted Cancer Stem Cell Therapeutics: An Update. | Curr Top Med Chem | 2025 | https://conductscience.org/library/papers/38288804 | PubMed |
| 37366353 | Skin Cancer: An Insight on its Association with Aging, Pathogenesis and Treatment Strategies. | Curr Drug Res Rev | 2024 | https://conductscience.org/library/papers/37366353 | PubMed |
| 37324942 | EIF4a3-regulated circRABL2B regulates cell stemness and drug sensitivity of lung cancer via YBX1-dependent downregulation of MUC5AC expression. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37324942 | PubMed |
| 36994474 | Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype. | Mol Cells | 2023 | https://conductscience.org/library/papers/36994474 | PubMed |
| 36675033 | Cannot Target What Cannot Be Seen: Molecular Imaging of Cancer Stem Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36675033 | PubMed |
| 36661704 | Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems. | Curr Oncol | 2023 | https://conductscience.org/library/papers/36661704 | PubMed |
| 36498571 | Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy. | J Clin Med | 2022 | https://conductscience.org/library/papers/36498571 | PubMed |
| 36385964 | WDR72 Enhances the Stemness of Lung Cancer Cells by Activating the AKT/HIF-1α Signaling Pathway. | J Oncol | 2022 | https://conductscience.org/library/papers/36385964 | PubMed |
| 36362359 | The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36362359 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCG2 | 9429 | PubTator's text mining | https://conductscience.org/library/genes/9429 | NCBI Gene |
| MCM7 | 4176 | PubTator's text mining | https://conductscience.org/library/genes/4176 | NCBI Gene |
| TERT | 7015 | PubTator's text mining | https://conductscience.org/library/genes/7015 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17510412
GET https://conductscience.org/api/papers/v1/17510412/cited_by?page=2